期 |
栏目 |
标题 |
文件 |
卷 82, 编号 5 (2010) |
Editorial |
Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS |
|
卷 83, 编号 5 (2011) |
Editorial |
Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics) |
|
卷 84, 编号 5 (2012) |
Editorial |
SURVIVAL OF GOUT PATIENTS |
|
卷 91, 编号 5 (2019) |
Editorial |
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 92, 编号 5 (2020) |
Original articles |
Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 93, 编号 5 (2021) |
Reviews |
Advantages of the use of metformin in patients with impaired uric acid metabolism |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 95, 编号 5 (2023) |
Original articles |
Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 96, 编号 5 (2024) |
Original articles |
Uric acid, cognitive disorders, neurodegeneration |
![PDF](/img/labels/pdf.png) (Rus)
|